38163846|t|Transport and inhibition mechanism for VMAT2-mediated synaptic vesicle loading of monoamines.
38163846|a|Monoamine neurotransmitters such as serotonin and dopamine are loaded by vesicular monoamine transporter 2 (VMAT2) into synaptic vesicles for storage and subsequent release in neurons. Impaired VMAT2 function underlies various neuropsychiatric diseases. VMAT2 inhibitors reserpine and tetrabenazine are used to treat hypertension, movement disorders associated with Huntington's Disease and Tardive Dyskinesia. Despite its physiological and pharmacological significance, the structural basis underlying VMAT2 substrate recognition and its inhibition by various inhibitors remains unknown. Here we present cryo-EM structures of human apo VMAT2 in addition to states bound to serotonin, tetrabenazine, and reserpine. These structures collectively capture three states, namely the lumen-facing, occluded, and cytosol-facing conformations. Notably, tetrabenazine induces a substantial rearrangement of TM2 and TM7, extending beyond the typical rocker-switch movement. These functionally dynamic snapshots, complemented by biochemical analysis, unveil the essential components responsible for ligand recognition, elucidate the proton-driven exchange cycle, and provide a framework to design improved pharmaceutics targeting VMAT2.
38163846	39	44	VMAT2	Gene	6571
38163846	82	92	monoamines	Chemical	-
38163846	94	121	Monoamine neurotransmitters	Chemical	-
38163846	130	139	serotonin	Chemical	MESH:D012701
38163846	144	152	dopamine	Chemical	MESH:D004298
38163846	167	200	vesicular monoamine transporter 2	Gene	6571
38163846	202	207	VMAT2	Gene	6571
38163846	288	293	VMAT2	Gene	6571
38163846	321	346	neuropsychiatric diseases	Disease	MESH:D004194
38163846	348	353	VMAT2	Gene	6571
38163846	365	374	reserpine	Chemical	MESH:D012110
38163846	379	392	tetrabenazine	Chemical	MESH:D013747
38163846	411	423	hypertension	Disease	MESH:D006973
38163846	425	443	movement disorders	Disease	MESH:D009069
38163846	460	480	Huntington's Disease	Disease	MESH:D006816
38163846	485	503	Tardive Dyskinesia	Disease	MESH:D004409
38163846	597	602	VMAT2	Gene	6571
38163846	721	726	human	Species	9606
38163846	731	736	VMAT2	Gene	6571
38163846	768	777	serotonin	Chemical	MESH:D012701
38163846	779	792	tetrabenazine	Chemical	MESH:D013747
38163846	798	807	reserpine	Chemical	MESH:D012110
38163846	939	952	tetrabenazine	Chemical	MESH:D013747
38163846	1313	1318	VMAT2	Gene	6571
38163846	Association	MESH:D004409	6571
38163846	Association	MESH:D006973	6571
38163846	Association	MESH:D004298	6571
38163846	Negative_Correlation	MESH:D012110	6571
38163846	Association	MESH:D004194	6571
38163846	Negative_Correlation	MESH:D013747	MESH:D006973
38163846	Negative_Correlation	MESH:D012110	MESH:D004409
38163846	Association	MESH:D006816	6571
38163846	Association	MESH:D012701	6571
38163846	Negative_Correlation	MESH:D012110	MESH:D006973
38163846	Negative_Correlation	MESH:D012110	MESH:D009069
38163846	Negative_Correlation	MESH:D013747	MESH:D009069
38163846	Negative_Correlation	MESH:D013747	MESH:D004409
38163846	Association	MESH:D009069	6571
38163846	Negative_Correlation	MESH:D013747	6571
38163846	Negative_Correlation	MESH:D012110	MESH:D006816
38163846	Negative_Correlation	MESH:D013747	MESH:D006816

